Israeli bio-tech Proteologics Ltd. announced successful results in its pre-clinical trial of the PRT0467 drug candidate for the treatment of rheumatoid arthritis. Injections of the drug in mice found a statistically significant reduction in the inflammation response.
http://www.globes.co.il/serveen/globes/docview.asp?did=1000706711